CORE LABORATORIES N.V. Operating Income
CORE LABORATORIES N.V. reported Operating Income of $6.48 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-27.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-04-27
- CORE LABORATORIES N.V. operating income (loss) for the quarter ending 2023-03-31 was $6.48M.
- CORE LABORATORIES N.V. operating income (loss) for the quarter ending 2022-12-31 was $15.62M, a 9.99% increase year-over-year.
- CORE LABORATORIES N.V. operating income (loss) for the quarter ending 2022-09-30 was $14.64M, a 120.56% increase year-over-year.
- CORE LABORATORIES N.V. operating income (loss) for the quarter ending 2022-06-30 was $11.65M, a 8.97% decline year-over-year.
- CORE LABORATORIES N.V. operating income (loss) for fiscal 2022 was $41.52M, a 8.26% decline from fiscal 2021.
- CORE LABORATORIES N.V. operating income (loss) for fiscal 2021 was $45.26M.
- CORE LABORATORIES N.V. operating income (loss) for fiscal 2020 was -$76.81M, a 179.44% decline from fiscal 2019.
- CORE LABORATORIES N.V. operating income (loss) for fiscal 2019 was $96.68M, a 18.49% decline from fiscal 2018.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-03-31 | $6.48M 10-Q · filed 2023-04-27 | $22.10M derived: sum of 2 quarters · filed 2023-04-27 | $36.74M derived: sum of 3 quarters · filed 2023-04-27 | $48.40M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-12-31 | $15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $30.26M derived: sum of 2 quarters · filed 2023-02-10 | $41.91M derived: sum of 3 quarters · filed 2023-02-10 | $41.52M 10-K · filed 2023-02-10 |
| 2022-09-30 | $14.64M 10-Q · filed 2022-10-28 | $26.30M derived: sum of 2 quarters · filed 2022-10-28 | $25.91M 10-Q · filed 2022-10-28 | $40.11M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-06-30 | $11.65M 10-Q · filed 2022-07-28 | $11.26M 10-Q · filed 2022-07-28 | $25.46M derived: sum of 3 quarters · filed 2023-04-27 | $32.10M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-03-31 | -$391.00K 10-Q · filed 2023-04-27 | $13.81M derived: sum of 2 quarters · filed 2023-04-27 | $20.45M derived: sum of 3 quarters · filed 2023-04-27 | $33.25M derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $20.84M derived: sum of 2 quarters · filed 2023-02-10 | $33.64M derived: sum of 3 quarters · filed 2023-02-10 | $45.26M 10-K · filed 2023-02-10 |
| 2021-09-30 | $6.64M 10-Q · filed 2022-10-28 | $19.44M derived: sum of 2 quarters · filed 2022-10-28 | $31.06M 10-Q · filed 2022-10-28 | $54.47M derived: sum of 4 quarters · filed 2022-10-28 |
| 2021-06-30 | $12.80M 10-Q · filed 2022-07-28 | $24.42M 10-Q · filed 2022-07-28 | $47.83M derived: sum of 3 quarters · filed 2022-07-28 | $59.16M derived: sum of 4 quarters · filed 2022-07-28 |
| 2021-03-31 | $11.62M 10-Q · filed 2022-04-28 | $35.03M derived: sum of 2 quarters · filed 2022-04-28 | $46.36M derived: sum of 3 quarters · filed 2022-04-28 | $43.79M derived: sum of 4 quarters · filed 2022-04-28 |
| 2020-12-31 | $23.40M 10-K · filed 2021-02-08 | $34.73M derived: sum of 2 quarters · filed 2021-10-29 | $32.17M derived: sum of 3 quarters · filed 2021-10-29 | -$76.81M 10-K · filed 2023-02-10 |
| 2020-09-30 | $11.33M 10-Q · filed 2021-10-29 | $8.76M derived: sum of 2 quarters · filed 2021-10-29 | -$100.21M 10-Q · filed 2021-10-29 | -$79.15M derived: sum of 4 quarters · filed 2021-10-29 |
| 2020-06-30 | -$2.57M 10-Q · filed 2021-07-30 | -$111.54M 10-Q · filed 2021-07-30 | -$90.48M derived: sum of 3 quarters · filed 2021-07-30 | -$59.28M derived: sum of 4 quarters · filed 2021-07-30 |
| 2020-03-31 | -$108.97M 10-Q · filed 2021-04-23 | -$87.92M derived: sum of 2 quarters · filed 2021-04-23 | -$56.71M derived: sum of 3 quarters · filed 2021-04-23 | -$28.70M derived: sum of 4 quarters · filed 2021-04-23 |
| 2019-12-31 | $21.05M 10-K · filed 2021-02-08 | $52.26M derived: sum of 2 quarters · filed 2021-02-08 | $80.27M derived: sum of 3 quarters · filed 2021-02-08 | $96.68M 10-K · filed 2022-02-10 |
| 2019-09-30 | $31.21M 10-K · filed 2021-02-08 | $59.22M derived: sum of 2 quarters · filed 2021-02-08 | $75.63M 10-Q · filed 2020-10-22 | $93.61M derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-06-30 | $28.01M 10-K · filed 2021-02-08 | $44.42M 10-Q · filed 2020-07-24 | $62.40M derived: sum of 3 quarters · filed 2021-02-08 | $97.28M derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-03-31 | $16.41M 10-K · filed 2021-02-08 | $34.39M derived: sum of 2 quarters · filed 2021-02-08 | $69.27M derived: sum of 3 quarters · filed 2021-02-08 | $102.72M derived: sum of 4 quarters · filed 2021-02-08 |
| 2018-12-31 | $17.98M 10-K · filed 2020-02-10 | $52.86M derived: sum of 2 quarters · filed 2020-02-10 | $86.31M derived: sum of 3 quarters · filed 2020-02-10 | $118.62M 10-K · filed 2021-02-08 |
| 2018-09-30 | $34.88M 10-K · filed 2020-02-10 | $68.33M derived: sum of 2 quarters · filed 2020-02-10 | $100.64M 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $33.45M 10-K · filed 2020-02-10 | $65.77M 10-Q · filed 2019-07-26 | ||
| 2018-03-31 | $32.32M 10-K · filed 2020-02-10 | |||
| 2017-12-31 | $109.97M 10-K · filed 2020-02-10 | |||
| 2016-12-31 | $87.45M 10-K · filed 2019-02-11 |